Overview

Bifeprunox Extension to Extension Study in Patients With Schizophrenia

Status:
Terminated
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide access to bifeprunox for patients, who have completed previous studies with bifeprunox, and require continued treatment with bifeprunox, other treatment not being adequate. A further purpose is to investigate the safety and side-effects of bifeprunox during long-term treatment.
Phase:
Phase 3
Details
Lead Sponsor:
H. Lundbeck A/S
Collaborator:
Solvay Pharmaceuticals